deferoxamine has been researched along with picolinic acid in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, JE; Sheen, YY | 1 |
| Bosco, MC; Melillo, G; Negrioli, A; Pastorino, S; Rapella, A; Varesio, L | 1 |
| Bosco, MC; Massazza, S; Melillo, G; Mi, Z; Pastorino, S; Puppo, M; Rapisarda, A; Varesio, L | 1 |
| Bosco, MC; Carta, L; Melillo, G; Pastorino, S; Puppo, M; Varesio, L | 1 |
4 other study(ies) available for deferoxamine and picolinic acid
| Article | Year |
|---|---|
Nitric oxide inhibits dioxin action for the stimulation of Cyp1a1 promoter activity.
Topics: Animals; Arginine; Cells, Cultured; Cobalt; Cytochrome P-450 CYP1A1; Deferoxamine; Dioxins; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Genes, Reporter; Lipopolysaccharides; Luciferases; Mice; Nitric Oxide; Nitroarginine; Nitroprusside; Picolinic Acids; Polychlorinated Dibenzodioxins; Promoter Regions, Genetic; Teratogens; Transfection | 2000 |
Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma.
Topics: Antineoplastic Agents; Cell Hypoxia; Deferoxamine; Endothelial Growth Factors; Ferrous Compounds; Flavonoids; Gene Expression; Humans; Iron Chelating Agents; Lymphokines; Neuroblastoma; Picolinic Acids; Piperidines; RNA, Messenger; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2002 |
Hypoxia selectively inhibits monocyte chemoattractant protein-1 production by macrophages.
Topics: Animals; Cell Hypoxia; Cell Line; Cell Line, Tumor; Chemokine CCL2; Deferoxamine; Down-Regulation; Gene Expression Regulation; Humans; Interferon-gamma; Lipopolysaccharides; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Oxygen; Picolinic Acids; RNA Stability; RNA, Messenger; Transcription, Genetic | 2004 |
Picolinic acid- or desferrioxamine-inducible autocrine activation of macrophages engineered to produce IFNgamma: an approach for gene therapy.
Topics: Animals; Autocrine Communication; Cell Line; Deferoxamine; Drug Synergism; Genetic Therapy; Genetic Vectors; Interferon-gamma; Iron; Iron Chelating Agents; Macrophage Activation; Macrophages; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Phagocytosis; Picolinic Acids; Stimulation, Chemical; Transfection; Tumor Necrosis Factor-alpha | 2004 |